• Home
  • Search Results

Search Results

Open
Cancer
190 studies match your search
Open

Study of AUTX-007 for Leukemia

If you have Leukemia and are looking for an alternative treatment, you may be eligible to participate in a research study testing a new drug called AUTX-007.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Safety and Efficacy of ABBV-453 in Monotherapy or in Combination with Antimyeloma Regimens

Have you been diagnosed with relapsed or refractory multiple myeloma? If so, you may be able to take part in a research study looking at the safety and tolerability of giving a new drug called ABBV-453 alone and in combination with other antimyeloma drugs to patients with relapsed or refractory multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

PREDICT-RD: ctDNA Surveillance in TNBC with Residual Disease

Have you been diagnosed with stage II or III triple negative breast cancer (TNBC) and have residual disease after therapy, but haven't had surgery yet? If so, you may be able to take part in a research study examining how often cancer DNA in the blood (called ctDNA) can be used to detect minimal residual disease (MRD) and early signs of cancer returning after surgery. Some participants who test positive for ctDNA but show no signs of cancer on scans may receive a study drug called Dato-DXd if they qualify.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Research Study for High-Risk Head and Neck Cancer

Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN

Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Young Adult Alcohol Use and Social Media Study

Are you a young adult who drinks and uses social media? We are holding in-person workshops in downtown Chapel Hill to gather feedback from young adults who drink and use social media. Compensation provided.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Breast, Colorectal, Head and Neck, and 2 more)
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Open

Metastatic Triple Negative Breast Cancer Study

Are you battling triple-negative breast cancer? If your cancer has come back or spread, and you haven't started treatment yet, you might qualify for a clinical trial testing a new medication. Discover more about this opportunity to find a potentially better treatment option.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Open

Detect-ME

Do you have acid reflux, GERD, or Barrett's Esophagus? Are you having standard of care endoscopies performed? You may be able to participate in a research study testing for Barrett's Esophagus and esophageal cancer. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
  • Stomach, Digestion and Gut Health
Open

Epcoritamab in Previously Treated WM

Have you been diagnosed with Waldenstrom Macroglobulinemia (WM) cancer? If so, you may be able to take part in a research study to determine if epcoritamab can be used to treat patients with previously treated WM.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Lymphoma)
Open

QuantifyHER

This trial seeks to enroll patients diagnosed with HER2-negative (HER2- low or HER2-0)- MBC who are starting treatment with T-DXd. The purpose is to determine if the test used for HER2+ MBC also works for HER2-low MBC. By participating in this trial, you are contributing to information that may improve the care of future patients with HER2-negative (HER2- low or HER2-0)- MBC. This trial does not require additional biopsies. Only tissue left over from a standard-of-care procedure will be used. The study team will access your medical record to review routine imaging test results as well as track your response to your treatment. Your breast cancer care will be managed by your oncologist, and you won't need to interact with the study team for direct care. No extra visits with the study team are required, except possibly for the initial enrollment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research